ArticleResearch and practice in thrombosis and haemostasis2024

Pharmacokinetics and coagulation biomarkers in children and adults with hemophilia A receiving emicizumab prophylaxis every 1, 2, or 4 weeks.

Anna Kiialainen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.